| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/08/2023 | EXACT SCIENCES CORP | EXAS | Grant | Common Stock | 3.6k | $0.00 | $0 | | 06/08/2023 |
| 05/24/2023 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Common Stock | 4.6k | $0.00 | $0 | | 05/24/2023 |
| 05/24/2023 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Stock Option (Right to Buy) | 13.8k | $32.27 | $444.5k | | 05/24/2023 |
| 02/22/2023 | 1Life Healthcare Inc | ONEM | Disposition | Common Stock | 4.5k | $18.00 | $81.6k | | 02/22/2023 |
| 02/22/2023 | 1Life Healthcare Inc | ONEM | Disposition | Stock Options (Right to buy) | 10.4k | $11.56 | $120k | | 02/22/2023 |
| 02/22/2023 | 1Life Healthcare Inc | ONEM | Disposition | Stock Option (Right to Buy) | 5.3k | $29.00 | $153.5k | | 02/22/2023 |
| 02/22/2023 | 1Life Healthcare Inc | ONEM | Disposition | Restricted Stock Units | 20.7k | $0.00 | $0 | | 02/22/2023 |
| 06/09/2022 | EXACT SCIENCES CORP | EXAS | Grant | Common Stock | 5.6k | $0.00 | $0 | | 06/09/2022 |
| 06/02/2022 | 1Life Healthcare Inc | ONEM | Exercise | Restricted Stock Units | 4.5k | $0.00 | $0 | | 06/02/2022 |
| 06/02/2022 | 1Life Healthcare Inc | ONEM | Grant | Restricted Stock Units | 20.7k | $0.00 | $0 | | 06/02/2022 |
| 05/19/2022 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Common Stock | 4.8k | $0.00 | $0 | | 05/19/2022 |
| 05/19/2022 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Stock Option (Right to Buy) | 15.3k | $35.42 | $542.6k | | 05/19/2022 |
| 03/31/2022 | Pyxis Oncology, Inc. | PYXS | Grant | Common Stock | 66.8k | $0.00 | $0 | | 03/31/2022 |
| 10/07/2021 | Pyxis Oncology, Inc. | PYXS | Grant | Stock Option (Right to buy) | 42.2k | $16.00 | $675.1k | | 10/07/2021 |
| 06/03/2021 | 1Life Healthcare Inc | ONEM | Grant | Restricted Stock Units | 4.5k | $0.00 | $0 | | 06/03/2021 |
| 05/20/2021 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Common Stock | 1.1k | $0.00 | $0 | | 05/20/2021 |
| 05/20/2021 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Stock Option (Right to Buy) | 7k | $75.94 | $531.4k | | 05/20/2021 |
| 07/23/2020 | EXACT SCIENCES CORP | EXAS | Grant | | 3.4k | $0.00 | $0 | | 07/23/2020 |
| 05/20/2020 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Stock Option (Right to Buy) | 7.5k | $38.03 | $283.9k | | 05/20/2020 |
| 05/14/2020 | 1Life Healthcare Inc | ONEM | Grant | Stock Option (Right to Buy) | 5.3k | $29.00 | $153.5k | | 05/14/2020 |
| 04/22/2020 | EXACT SCIENCES CORP | EXAS | Grant | | 5.1k | $0.00 | $0 | | 04/22/2020 |
| 09/17/2019 | SpringWorks Therapeutics, Inc. | SWTX | Conversion | Series B Convertible Preferred Stock | 526.6k | $0.00 | $0 | By: Pfizer Ventures (US) LLC | 09/17/2019 |
| 09/17/2019 | SpringWorks Therapeutics, Inc. | SWTX | Conversion | Common Stock | 978.2k | $0.00 | $0 | By: Pfizer Inc. | 09/17/2019 |
| 09/17/2019 | SpringWorks Therapeutics, Inc. | SWTX | Conversion | Common Stock | 3M | $0.00 | $0 | By: Pfizer Inc. | 09/17/2019 |
| 09/17/2019 | SpringWorks Therapeutics, Inc. | SWTX | Conversion | Common Stock | 526.6k | $0.00 | $0 | By: Pfizer Ventures (US) LLC | 09/17/2019 |
| 09/17/2019 | SpringWorks Therapeutics, Inc. | SWTX | Purchase | Common Stock | 50k | $18.00 | $900k | By: Pfizer Ventures (US) LLC | 09/17/2019 |
| 09/17/2019 | SpringWorks Therapeutics, Inc. | SWTX | Conversion | Junior Series A Convertible Preferred Stock | 978.2k | $0.00 | $0 | By: Pfizer Inc. | 09/17/2019 |
| 09/17/2019 | SpringWorks Therapeutics, Inc. | SWTX | Conversion | Series A Convertible Preferred Stock | 3M | $0.00 | $0 | By: Pfizer Inc. | 09/17/2019 |
| 09/12/2019 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Stock Option (Right to Buy) | 30k | $18.00 | $539.7k | | 03/29/2019 |
| 03/29/2019 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Junior Series A Convertible Preferred Stock | 6.4M | $0.00 | $0 | By Pfizer Inc. | 03/29/2019 |
| 03/29/2019 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Series A Convertible Preferred Stock | 20M | $0.00 | $0 | By Pfizer Inc. | 03/29/2019 |
| 03/29/2019 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Series B Convertible Preferred Stock | 3.5M | $0.00 | $0 | By Pfizer Ventures (US) LLC | 03/29/2019 |
| 02/28/2019 | PFIZER INC | PFE | Grant | Stock Appreciation Rights | 54.2k | $43.35 | $2.3M | | 02/27/2019 |
| 02/28/2019 | PFIZER INC | PFE | Grant | Stock Appreciation Rights | 45.6k | $43.35 | $2M | | 02/27/2019 |
| 02/27/2019 | PFIZER INC | PFE | Payment of Exercise | Common Stock | 23.6k | $42.93 | $1M | | 02/27/2019 |
|